Michele Rhee MBA, MPH

Michele joined Enzyvant as the Head of Patient Affairs, following patient advocacy leadership roles at the National Brain Tumor Society, bluebird bio, and Takeda Oncology. As a member of the rare disease and cancer patient communities for over a decade, Michele has dedicated her career to getting treatments to the patients who need them. She received her MBA from the Yale School of Management and her MPH from the Yale School of Public Health.